Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 748 clinical trials
Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer (PLUMMB)

PLUMMB is an phase I trial to investigate the safety, tolerability and effectiveness of an immunotherapy drug called Pembrolizumab used in combination with radiotherapy. The study will also

measurable disease
pembrolizumab
carcinoma
bladder cancer
ct scans
  • 0 views
  • 25 Jan, 2022
  • 1 location
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma

The study aims to evaluate the safety and preliminary efficacy of the combination of cabozantinib and pembrolizumab in advanced melanoma

  • 0 views
  • 04 Oct, 2022
  • 1 location
Olinvacimab With Pembrolizumab in Patients With mTNBC

The objective is to evaluate the efficacy and safety of Olinvacimab in combination with Pembrolizumab in patients with mTNBC.

  • 1 views
  • 04 Oct, 2022
  • 1 location
Trial of Pembrolizumab in Cancer of Unknown Primary

Abbreviated Title : CUPem Clinical Indication : A Phase II, Two-Stage, Trial of Pembrolizumab in Cancer of unknown primary Trial Type : Single Arm, non-randomised; Two-stage; Hypothesis

  • 0 views
  • 22 Jan, 2021
  • 1 location
Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC (PAXIPEM)

Multicenter Phase II Study of Axitinib +/- Pembrolizumab in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)

  • 0 views
  • 07 Oct, 2022
  • 1 location
Pembrolizumab Plus Lenvatinib in Stage III-IV RCC

This is a phase II study to determine the efficacy and safety of Pembrolizumab when given in combination with Lenvatinib as treatment for patients with the advanced kidney cancer. Further

  • 0 views
  • 04 Oct, 2022
  • 1 location
Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mCRPC) patients (Part A) with a biomarker

docetaxel
flutamide
bone lesions
measurable disease
major surgery
  • 0 views
  • 24 Jan, 2021
  • 1 location
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma

Pembrolizumab monotherapy and platinum-based chemotherapy in the combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) have been widely

  • 0 views
  • 07 Oct, 2022
  • 1 location
Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma

The purpose of this study is to evaluate the safety and clinical activity of paclitaxel plus olaparib and pembrolizumab in patients with previously treated advanced Gastric Cancer (GC).

  • 0 views
  • 12 Mar, 2022
  • 1 location
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

Aim of the trial is to evaluate the activity and tolerability of the anti PD1 agent Pembrolizumab in combination with RadioTherapy for the initial treatment of previously untreated patients with

  • 0 views
  • 21 Apr, 2022
  • 1 location